Quest Diagnostics Incorporated DGX
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.35% | 13.48% | 14.55% | 10.36% | 8.41% |
| Total Depreciation and Amortization | 3.52% | 2.10% | 5.00% | 7.41% | 13.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.29% | -32.81% | 102.27% | -85.14% | 229.79% |
| Change in Net Operating Assets | -104.76% | 60.00% | -133.33% | 93.94% | 150.00% |
| Cash from Operations | 8.53% | 9.74% | -11.46% | 0.22% | 58.15% |
| Capital Expenditure | -15.28% | -27.78% | 2.56% | -28.46% | -35.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 97.06% | 100.00% | -- | 86.95% | 97.78% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.30% | 300.00% | -- | 325.00% | -483.33% |
| Cash from Investing | 15.92% | -8.06% | -32.17% | 61.95% | 87.69% |
| Total Debt Issued | -100.00% | 167.03% | -- | -- | -99.46% |
| Total Debt Repaid | 70.00% | -24.69% | 99.83% | 0.00% | -900.00% |
| Issuance of Common Stock | 42.11% | 23.08% | 124.14% | -14.29% | -20.83% |
| Repurchase of Common Stock | 0.00% | -- | 11.90% | -99.34% | -15,100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.74% | -6.67% | -4.76% | -7.14% | -5.95% |
| Other Financing Activities | -92.00% | -- | -15.19% | 93.33% | -78.57% |
| Cash from Financing | -9.72% | 21.84% | 72.91% | -68.82% | -113.95% |
| Foreign Exchange rate Adjustments | 100.00% | -125.00% | -200.00% | 114.29% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.33% | 77.86% | 92.52% | 94.42% | -77.08% |